Insider Buying Update for Wednesday, September 10: AXSM, ACDC
Axsome Therapeutics Insider Purchase: Mark Coleman purchased 1,575 shares of AXSM at $127.28 each, totaling $200,466, marking his first insider buy in the past year, while the stock is down about 0.5% on Wednesday.
ProFrac Holding Insider Purchase: Executive Chairman Matthew Wilks bought 43,297 shares of ACDC at $3.80 each for a total of $164,578, adding to previous investments totaling $1.05M at an average of $6.17 per share, with the stock up about 4.9% on Wednesday.
Trade with 70% Backtested Accuracy
Analyst Views on ACDC
About ACDC
About the author
ProFrac Holding Corp. (ACDC) Announces Q3 Loss and Falls Short of Revenue Projections
Quarterly Loss Report: ProFrac Holding Corp. reported a quarterly loss of $0.6 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.43, and a significant decline from a loss of $0.13 per share a year ago.
Revenue Performance: The company generated revenues of $403.1 million for the quarter, missing the consensus estimate by 0.58% and down from $575.3 million in the same quarter last year.
Stock Outlook: ProFrac's stock has underperformed, losing about 35.2% since the beginning of the year, and currently holds a Zacks Rank #5 (Strong Sell), indicating expectations of further underperformance in the near future.
Industry Context: The Oil and Gas - Field Services industry is currently ranked in the bottom 40% of Zacks industries, which may negatively impact ProFrac's stock performance, while another sector company, National Energy Services Reunited, is set to report its earnings soon.
Major Stocks Including Monday.Com, Metsera, and Profrac Holding Decline in Pre-Market Trading on Monday
U.S. Stock Futures: U.S. stock futures rose this morning, with Nasdaq futures increasing by approximately 1.5% on Monday.
Monday.Com Earnings: Shares of Monday.Com Ltd fell 2.6% in pre-market trading ahead of its quarterly earnings report, with analysts expecting earnings of 88 cents per share and revenue of $312.26 million.
Other Stocks Declining: Several stocks experienced declines in pre-market trading, including Metsera Inc, which dropped 15% after Pfizer's $10 billion acquisition deal, and Ionis Pharmaceuticals, which fell 11.5% following disappointing study results.
Market Overview: Other notable declines included Oscar Health Inc down 5.4%, Centene Corp down 4.8%, and Profrac Holding Corp down 2.8%, reflecting a generally negative trend among various stocks.
ProFrac Holding Announces Third Quarter Results
Q3 Financial Performance: ProFrac Holding reported Q3 revenue of $403.1 million, a 29.9% year-over-year decline, missing expectations by $16.19 million. The net loss was $92 million, an improvement from the $107 million loss in Q2 2025.
Adjusted EBITDA and Cash Flow: Adjusted EBITDA decreased to $41 million, representing 10% of revenue, down from 16% in Q2 2025. Net cash from operating activities fell to $5 million, and free cash flow was negative at $(29) million.
Outlook for Stimulation Services: The company anticipates improved activity levels in the Stimulation Services segment for Q4, despite expected lower pricing compared to Q3. Sequential improvement in results is expected.
Proppant Production Segment Expectations: ProFrac expects profitability in the Proppant Production segment to improve in Q4, driven by enhanced operational efficiency and increased throughput, despite ongoing pricing pressures.
Jim Cramer Advises Against Investing in This Tech Stock and Avoids Oil Companies
Jim Cramer's Take on Zoom: Jim Cramer stated that while Zoom Communications Inc. is a solid company, it currently lacks a catalyst for investment, advising to "take a pass" until after their Q3 financial results on Nov. 24.
ProFrac Holding Corp Outlook: Cramer expressed a negative stance on oil stocks, including ProFrac Holding Corp, stating he is "really anti the oils right now," and noted a recent downgrade in ProFrac's price target by Piper Sandler.
Viking Therapeutics Performance: Cramer recommended Eli Lilly over Viking Therapeutics, which reported a quarterly loss that exceeded analyst expectations, leading to a 3.8% drop in its share price.
Altria Group Earnings: Cramer refrained from recommending Altria Group but acknowledged its recent earnings report, which met expectations despite a decline in quarterly sales, resulting in a slight increase in its share price.
Cramer's Lightning Round: "I'll be skipping Zoom"
- Viking Therapeutics: The company is viewed positively, with a suggestion to "own Eli Lilly" as a strong investment choice.
- Altria Group: The speaker expresses personal reservations about recommending the stock but acknowledges its potential.
- Zoom: While the company is considered good, the lack of a compelling reason to recommend it leads to a decision to pass on investment.
- ProFrac: The speaker is currently negative on oil stocks, predicting a decline and advising against investment in that sector.
ProFrac Holding Corp. Schedules Earnings Release and Conference Call for Third Quarter 2025
Earnings Call Announcement: ProFrac Holding Corp. will report its third quarter 2025 financial results before a conference call scheduled for November 10, 2025, at 11:00 a.m. Eastern Time.
Webcast Availability: The conference call will be webcasted, and an archive will be accessible for 90 days on ProFrac's investor relations website.
Company Overview: ProFrac Holding Corp. is a technology-focused energy services holding company that provides hydraulic fracturing and related services to oil and gas companies in North America.
Business Segments: The company operates through three main segments: Stimulation Services, Proppant Production and Manufacturing, and Other Business Activities.
ProFrac Holding Corp. (ACDC) Announces Q3 Loss and Falls Short of Revenue Projections
Quarterly Loss Report: ProFrac Holding Corp. reported a quarterly loss of $0.6 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.43, and a significant decline from a loss of $0.13 per share a year ago.
Revenue Performance: The company generated revenues of $403.1 million for the quarter, missing the consensus estimate by 0.58% and down from $575.3 million in the same quarter last year.
Stock Outlook: ProFrac's stock has underperformed, losing about 35.2% since the beginning of the year, and currently holds a Zacks Rank #5 (Strong Sell), indicating expectations of further underperformance in the near future.
Industry Context: The Oil and Gas - Field Services industry is currently ranked in the bottom 40% of Zacks industries, which may negatively impact ProFrac's stock performance, while another sector company, National Energy Services Reunited, is set to report its earnings soon.
Major Stocks Including Monday.Com, Metsera, and Profrac Holding Decline in Pre-Market Trading on Monday
U.S. Stock Futures: U.S. stock futures rose this morning, with Nasdaq futures increasing by approximately 1.5% on Monday.
Monday.Com Earnings: Shares of Monday.Com Ltd fell 2.6% in pre-market trading ahead of its quarterly earnings report, with analysts expecting earnings of 88 cents per share and revenue of $312.26 million.
Other Stocks Declining: Several stocks experienced declines in pre-market trading, including Metsera Inc, which dropped 15% after Pfizer's $10 billion acquisition deal, and Ionis Pharmaceuticals, which fell 11.5% following disappointing study results.
Market Overview: Other notable declines included Oscar Health Inc down 5.4%, Centene Corp down 4.8%, and Profrac Holding Corp down 2.8%, reflecting a generally negative trend among various stocks.
ProFrac Holding Announces Third Quarter Results
Q3 Financial Performance: ProFrac Holding reported Q3 revenue of $403.1 million, a 29.9% year-over-year decline, missing expectations by $16.19 million. The net loss was $92 million, an improvement from the $107 million loss in Q2 2025.
Adjusted EBITDA and Cash Flow: Adjusted EBITDA decreased to $41 million, representing 10% of revenue, down from 16% in Q2 2025. Net cash from operating activities fell to $5 million, and free cash flow was negative at $(29) million.
Outlook for Stimulation Services: The company anticipates improved activity levels in the Stimulation Services segment for Q4, despite expected lower pricing compared to Q3. Sequential improvement in results is expected.
Proppant Production Segment Expectations: ProFrac expects profitability in the Proppant Production segment to improve in Q4, driven by enhanced operational efficiency and increased throughput, despite ongoing pricing pressures.
Jim Cramer Advises Against Investing in This Tech Stock and Avoids Oil Companies
Jim Cramer's Take on Zoom: Jim Cramer stated that while Zoom Communications Inc. is a solid company, it currently lacks a catalyst for investment, advising to "take a pass" until after their Q3 financial results on Nov. 24.
ProFrac Holding Corp Outlook: Cramer expressed a negative stance on oil stocks, including ProFrac Holding Corp, stating he is "really anti the oils right now," and noted a recent downgrade in ProFrac's price target by Piper Sandler.
Viking Therapeutics Performance: Cramer recommended Eli Lilly over Viking Therapeutics, which reported a quarterly loss that exceeded analyst expectations, leading to a 3.8% drop in its share price.
Altria Group Earnings: Cramer refrained from recommending Altria Group but acknowledged its recent earnings report, which met expectations despite a decline in quarterly sales, resulting in a slight increase in its share price.
Cramer's Lightning Round: "I'll be skipping Zoom"
- Viking Therapeutics: The company is viewed positively, with a suggestion to "own Eli Lilly" as a strong investment choice.
- Altria Group: The speaker expresses personal reservations about recommending the stock but acknowledges its potential.
- Zoom: While the company is considered good, the lack of a compelling reason to recommend it leads to a decision to pass on investment.
- ProFrac: The speaker is currently negative on oil stocks, predicting a decline and advising against investment in that sector.
ProFrac Holding Corp. Schedules Earnings Release and Conference Call for Third Quarter 2025
Earnings Call Announcement: ProFrac Holding Corp. will report its third quarter 2025 financial results before a conference call scheduled for November 10, 2025, at 11:00 a.m. Eastern Time.
Webcast Availability: The conference call will be webcasted, and an archive will be accessible for 90 days on ProFrac's investor relations website.
Company Overview: ProFrac Holding Corp. is a technology-focused energy services holding company that provides hydraulic fracturing and related services to oil and gas companies in North America.
Business Segments: The company operates through three main segments: Stimulation Services, Proppant Production and Manufacturing, and Other Business Activities.
